Security key
007002108
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 51,603,071
- Total 13F value
- $31,484,026
- Share change
- -4,252,966
- Put/Call ratio
- 0%
- SEC-reported price per share
- $0.61
- Number of holders
- 47
- Value change
- -$3,114,221
- Number of buys
- 20
- Number of sells
- 32
- Shares outstanding
- 9,599,852
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
47
Top holders
10
ACET full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Adicet Bio, Inc. SEC filings
Adicet Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 007002108
Recent filing periods:
Ownership snapshot
Top reported holders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: TANG CAPITAL MANAGEMENT LLC
Showing 1-6 of 15 holder rows.
Quick read
TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
TANG CAPITAL MANAGEMENT LLC
9.9%
ORBIMED ADVISORS LLC
119%
RA CAPITAL MANAGEMENT, L.P.
79%
GOLDMAN SACHS GROUP INC
40%
VANGUARD GROUP INC
33%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
9.9%
|
$6,208,827
8,223,612 shares
|
$0 | 31 Mar 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
119%
|
$8,642,591
11,447,140 shares
|
— | 31 Mar 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
79%
|
$5,693,455
7,541,000 shares
|
— | 31 Mar 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
40%
|
$2,881,500
3,816,556 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
33%
|
$2,420,441
3,205,882 shares
|
— | 31 Mar 2025 |
| Carlyle Group Inc. |
13F
Company
|
31%
|
$2,276,705
2,948,718 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
47
Shares
51,603,071
Rows available
47
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
56
Q2 2025 holders
47
Holder diff
-9
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend